Affiliation:
1. Department of Chemistry and Institute of Chemical Biology & Drug Discovery, Stony Brook University−State University of New York, Stony Brook, New York 11794-3400, United States
Funder
National Cancer Institute
Indena S.p.A.
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry
Reference137 articles.
1. Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
2. THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS
3. Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC).
4. Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. In Taxol®: Science and Applications; Suffness, M., Ed. CRC Press: New York, 1995; pp 317–375.
5. Georg, G. I.; Harriman, G. C. B.; Vander Velde, D. G.; Boge, T. C.; Cheruvallath, Z. S.; Datta, A.; Hepperle, M.; Park, H.; Himes, R.
H.; Jayasinghe, L. In Taxane Anticancer Agents: Basic Science and Current Status, ACS Symp. Series 583; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds. American Chemical Society: Washington, D.C. 1995; pp 217–232.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献